[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582682":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":10,"centralContacts":29,"locations":35,"responsibleParty":58,"collaborators":60,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"ZS Associates","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Participants with undiagnosed neuromuscular symptoms",null,[12,13,14],"Behavioral: Social media recruitment","Behavioral: Self-Assessment","Behavioral: Follow-up",[16,21,25],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"BEHAVIORAL","Social media recruitment","Social media users exposed to a variety of paid social media advertisements as a recruitment tool for study enrollment",[9],{"type":17,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Self-Assessment","Eligible participants are asked to complete self-administered physical tests to assess inducible fatigue of specific muscle groups",[9],{"type":17,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Follow-up","Patients triaged based on their assessed risk of MG are asked to complete recommended follow-up with a clinician to determine presence of myasthenia gravis",[9],[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Ananda Vishnu Pandurangadu, MD","CONTACT","1-847-448-1001","support@unearthrootcause.com",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Evanston","Illinois","60201","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-87.69006,42.04114,{"lat":47,"lon":46},[50,53,55],{"name":51,"role":32,"phone":52,"phoneExt":10,"email":34},"Ananda V Pandurangadu, MD","847-448-1001",{"name":51,"role":54,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Pritikanta Paul, MD","SUB_INVESTIGATOR",{"type":54,"investigatorFullName":31,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Senior Consultant",[61,63],{"name":62,"class":6},"UCB Pharma",{"name":64,"class":65},"University of California, San Francisco","OTHER","100582682","validation-and-scaling-of-screening-program-for-undiagnosed-myasthenia-gravis-social-media-campaign-paired-with-a-self-moderated-assessment-100582682",false,"NCT06866483","Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment","Inclusion Criteria:\n\n* Reside within the 50 states of the United States at the time of enrollment\n* Age 19 or older if reside in Nebraska or Alabama, Age 21 or older if reside in Mississippi, Age 18 years or older if reside in any other state\n* Active email account\n* Fluency in English (spoken \u002F written), as demonstrated by the ability to read and sign the Informed Consent Form\n\nExclusion Criteria:\n\n* Live in an overseas territory of the United States\n* Inability or unwillingness to provide written informed consent\n* Diagnosed myasthenia gravis, including sero-negative MG\\*\n* Diagnosed multiple sclerosis\n* Have speech impairment, eye\u002Farm\u002Fleg weakness due to diagnosed brain cancer, or stroke",true,"ALL","18 Years",{"count":76,"type":77},1000,"ESTIMATED","OBSERVATIONAL","This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).",[81,82,83],"Myasthenia Gravis","Neuromuscular Disease","Neuromuscular Manifestations",[85,86],"social media","myasthenia gravis","2025-03-04",{"date":89,"type":90},"2025-03-10","ACTUAL",{"date":92,"type":90},"2025-02-26",{"date":94,"type":77},"2025-12-31",{"name":5,"class":6},1]